Pharmacoeconomic Evaluation of Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement in Spain

  1. Gómez-Outes, A.
  2. Avendaño-Solá, C.
  3. Terleira-Fernández, A.I.
  4. Vargas-Castrillón, E.
Aldizkaria:
PharmacoEconomics

ISSN: 1179-2027 1170-7690

Argitalpen urtea: 2014

Alea: 32

Zenbakia: 9

Orrialdeak: 919-936

Mota: Artikulua

DOI: 10.1007/S40273-014-0175-5 GOOGLE SCHOLAR